Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysis

S Maleknia, MJ Tavassolifar, F Mottaghitalab… - Molecular …, 2022 - Springer
… In the continuum, to introduce diagnostic biomarkerbiomarker panels related to WB
and NP samples that could accurately distinguish COVID-19 patients from HCs and non-COVID

IL-6 and other biomarkers as predictors of severity in COVID-19

N Broman, K Rantasärkkä, T Feuth, M Valtonen… - Annals of …, 2021 - Taylor & Francis
… organ damage in COVID-19. The severity of disease may be measured by different biomarkers.
… We consider IL-6 measurement to be a useful biomarker in clinical care of COVID-19

RNA Sequencing in COVID-19 patients identifies neutrophil activation biomarkers as a promising diagnostic platform for infections

R Wargodsky, P Dela Cruz, J LaFleur, D Yamane… - PloS one, 2022 - journals.plos.org
… Severe disease, termed COVID-19, involves acute … identify biomarkers for disease severity,
blood RNA from COVID-19 patient … Both SARS-CoV2 infection and the severity of COVID-19

Role of hematological parameters in COVID-19 patients in the emergency room

E Usul, İ Şan, B Bekgöz, A Şahin - Biomarkers in Medicine, 2020 - Taylor & Francis
… the roles of biomarkers from a peripheral blood sample in the diagnosis of COVID-19 patients
who … Materials & methods: Peripheral blood parameters, systemic inflammatory index (SII), …

Plasma linoleate diols are potential biomarkers for severe COVID-19 infections

CB McReynolds, I Cortes-Puch, R Ravindran… - Frontiers in …, 2021 - frontiersin.org
… As an example, the blood levels of the EpOMEs we report here in COVID-19 patients are
approximately 10 × higher than levels found in ICU-admitted burn patients (Kosaka et al., 1994)…

Novel biomarkers for the prediction of COVID-19 progression a retrospective, multi-center cohort study

Y Yu, T Liu, L Shao, X Li, CK He, M Jamal, Y Luo… - Virulence, 2020 - Taylor & Francis
coronavirus 2 (SARS-CoV-2) is spreading worldwide. Up to date, there is no efficient biomarker
for the … To analyze the inflammatory profiles of COVID-19 patients and demonstrate their …

Inhibitory immune checkpoint receptors and ligands as prognostic biomarkers in COVID-19 patients

MA Al-Mterin, A Alsalman, E Elkord - Frontiers in immunology, 2022 - frontiersin.org
bloodblood CD4+ and CD8+ T lymphocytes in COVID-19 patients of all ages, compared
with healthy controls (26, 39, 43). PD-1 was found to be upregulated on both peripheral blood

Artificial intelligence approach towards assessment of condition of COVID-19 patients-Identification of predictive biomarkers associated with severity of clinical …

A Blagojević, T Šušteršič, I Lorencin, SB Šegota… - Computers in biology …, 2021 - Elsevier
… of COVID-19 disease. Classification of patients is based on the values of blood biomarkers
that … Based on changes in blood biomarkers during two weeks' time, we aim to predict the …

Prognostic peripheral blood biomarkers at ICU admission predict COVID-19 clinical outcomes

M Messing, MS Sekhon, MR Hughes, S Stukas… - Frontiers in …, 2022 - frontiersin.org
… Here we focused on the development of an immunological biomarker screen that, at ICU
admission for COVID-19, predicts length of ICU stay or death. We offer these biomarkers as a …

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

S Xu, I Ilyas, J Weng - Acta Pharmacologica Sinica, 2023 - nature.com
… clinical manifestations of COVID-19 patients. The purpose of this review is to provide a
latest summary of biomarkers associated with endothelial cell activation in COVID-19 and offer …